Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 524-530

  Ehrmann, David A ^a,b   Cavaghan, Melissa K ^a   Imperial, Jacqueline ^a   Sturis, Jeppe ^a   Rosenfield, Robert L ^a   Polonsky, Kenneth S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; METFORMIN; PRASTERONE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; ESTROGEN METABOLISM; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; LUTEINIZING HORMONE BLOOD LEVEL; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROGESTERONE METABOLISM;

ADULT; ANDROGENS; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; GONADOTROPINS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; OVARY; POLYCYSTIC OVARY SYNDROME; STEROIDS;

EID: 0031015005     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.524     Document Type: Article

References (48)

1. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. 1986 Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 62:904-910.
2. Cara JF, Rosenfield RL. 1988 Insulin-like growth factor-I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecainterstitial cells. Endocrinology. 123:733-739.
3. Stuart DA, Nagamani M. 1992 Acute augmentation of plasma androstenedione and dehydroepiandrosterone by euglycemic insulin infusion: evidence for a direct effect of insulin on ovarian steroidogenesis. In: Dunaif A, Givens J, Haseltine F, Merriam G, eds. Current issues in endocrinology and metabolism: polycystic ovary syndrome. Cambridge: Blackwell; 279-288.
4. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and/or hyperinsulinemia. J Clin Endocrinol Metab. 65:499-507.
5. Ehrmann DA, Sturis J, Byrne M, Karrison T, Rosenfield RL, Polonsky KS. 1995 Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin dependent diabetes mellitus. J Clin Invest. 96:520-527.
6. Dunaif A, Finegood DT. 1996 β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 81:942-947.
7. Ehrmann DA, Rosenfield RL, Barnes RB, Karrison T. A longitudinal study of glucose tolerance in women with polycystic ovary syndrome [Abstract OR26-8]. Proc of the 10th Int Congr of Endocrinol. 1996.
8. Kiddy DS, Hamilton-Fairley D, Bush A, et al. 1992 Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 36:105-111.
9. Nestler JE, Barlascini CO, Matt DW, et al. 1989 Suppression of serum insulin levels by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 68:1027-1032.
10. Velazquez EM, Mendoza S, Hamer T, et al. 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism. 43:647-654.
11. Crave J-C, Fimbel S, Lejeune H, Cugnardey N, Dechaud H, Pugeat M. 1995 Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab. 80:2057-2062.
12. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 327:157-162.
13. Rosenfield RL, Barnes RB, Cara JF, Lucky AW. 1990 Dysregulation of cytochrome P450c17α as the cause of polycystic ovary syndrome. Fertil Steril. 53:785-791.
14. Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA. 1989 Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 320:559-565.
15. Adams J, Poison DW, Franks S. 1986 Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J. 293:355-359.
16. WHO Expert Committee. 1980 Second report on diabetes mellitus. Tech Rep Ser 646. Geneva: WHO.
17. Valdes CT, Elkind-Hirsch KE. 1991 Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocrinol Metab. 72:642-646.
18. Diamond MP, Simonson DC, DeFronzo RA. 1989 Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril. 52:204-208.
19. Kissebah AH. 1992 Upper body obesity: abnormalities in the metabolic profile and the androgenic/estrogenic balance. In: Dunaif A, Givens J, Haseltine F, Merriam G, eds. Current issues in endocrinology and metabolism: polycystic ovary syndrome. Cambridge: Blackwell; 359-374.
20. Mazess RB, Barden HS, Bisek JP, Hanson J. 1990 Dual-energy x-ray absorptiometry for total body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 51:1106-1112.
21. Bergman RN, Phillips LS, Cobelli C. 1981 Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 68:1456-1467.
22. Byrne MM, Sturis J, Polonsky KS. 1995 Insulin secretion and clearance during low-dose graded glucose infusion. Am J Physiol. 268:E21-E27.
23. O'Meara NM, Sturis J, Van Cauter E, Polonsky KS. 1993 Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest. 92:262-271.
24. Sturis J, Van Cauter E, Blackman JD, Polonsky KS. 1991 Entrainment of pulsatile insulin secretion by oscillatory glucose infusion. J Clin Invest. 87:439-445.
25. Morgan CR, Lazarow A. 1963 Immunoassay of insulin: two antibody systems: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes. 12:115-126.
26. Faber OK, Binder C, Markussen J, et al. 1978 Characterization of seven C-peptide antisera. Diabetes. 27:170-177.
27. Burstein S, Schaff-Blass E, Blass J, Rosenfield RL. 1985 The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics. J Clin Endocrinol Metab. 61:508-513.
28. Moll GW, Rosenfield RL, Heike JH. 1981 Estradiol-testosterone binding interactions and free plasma estradiol under physiological conditions. J Clin Endocrinol Metab. 52:868-876.
29. Bergman RN. 1989 Lilly Lecture 1989. Toward physiological understanding of glucose tolerance: minimal model approach. Diabetes. 38:1512-1527.
30. Kahn SE, Prigeon RL, McCulloch DK, et al. 1993 Quantification of the relationship between insulin sensitivity and B-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 42:1663-1672.
31. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. 1992 Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 41:368-377.
32. Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J. 1980 Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab. 51:520-528.
33. Polonsky KS, Licinio-Paixao J, Given BD, et al. 1986 Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and Type I diabetic patients. J Clin Invest. 77:98-105.
34. Sturis J, Polonsky KS, Shapiro ET, Blackman JD, O'Meara NM, Van Cauter E. 1992 Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients. Diabetalogia. 35:681-689.
35. Jenkins GM, Watts DG. 1968 Spectral analysis and its applications. San Francisco: Holden Day.
36. Pasquali R, Casimirri F, Venturoli D, et al. 1994 Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome. Metabolism. 6:706-713.
37. Ehrmann DA, Barnes RB, Rosenfield RL. 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism. Endocr Rev. 16:322-353.
38. Franks S, White DM, 1993 Prevalence of and etiological factors in polycystic ovarian syndrome. Ann NY Acad Sci. 687:112-114.
39. Sahin Y, Kelestimur F. 1993 17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome. Clin Endocrinol (Oxf). 39:151-155.
40. White DM, Donaldson M, Franks S. 1992 Hyperresponsiveness of LH to a single dose of GnRH analogue in ovulatory and anovulatory women with polycystic ovaries [Abstract]. J Endocrinol. 132(Suppl):306.
41. Ibañez L, Potau N, Virdis R, et al. 1993 Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 76:1599-1603.
42. Acbay O, Gundogdu S. 1996 Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril. 65:946-949.
43. Marks JB, Weber SL, Micell GR, Gutt M, Doherty K, Skyler JS. Metformin does not improve insulin sensitivity in insulin-resistant normoglycemic women with hirsutism [Abstract P2-639]. Proc of the 10th Int Congr of Endocrinol. 1996.
44. Fendri S, Debussche X, Puy H, et al. 1993 Metformin effects on peripheral sensitivity to insulin in non-diabetic obese subjects. Diabetes Metab. 19:245-249.
45. Olefsky JM, Reaven GM. 1974 Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart Diabetes. 23:449-453.
46. McDonald GW, Fisher GF, Burnham C. 1965 Reproducibility of the oral glucose tolerance test. Diabetes. 14:473-480.
47. O'Meara N, Blackman JD, Ehrmann DA, et al. 1993 Defects in beta cell function and insulin action in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 76:1241-1247.
48. Duleba AJ, Pawelczyk LA, Ho Yuen B, Moon YS. 1993 Insulin actions on ovarian steroidogenesis are not modulated by metformin. Hum Reprod. 8:1194-1198.